Who Exports Bisoprolol from India — 245 Suppliers Behind a $84.5M Market
India's bisoprolol export market is supplied by 245 active exporters who collectively shipped $84.5M across 4,276 shipments. UNICHEM LABORATORIES LIMITED leads with a 34.2% market share, followed by FREDUN PHARMACEUTICALS LTD and IPCA LABORATORIES LIMITED. The top 5 suppliers together control 74.9% of total export value, reflecting a concentrated market structure.
Top Bisoprolol Exporters from India — Ranked by Export Value
UNICHEM LABORATORIES LIMITED is the leading bisoprolol exporter from India, holding a 34.2% share of the $84.5M market across 4,276 shipments from 245 exporters. The top 5 suppliers — UNICHEM LABORATORIES LIMITED, FREDUN PHARMACEUTICALS LTD, IPCA LABORATORIES LIMITED, AUROBINDO PHARMA LTD, MEDREICH LIMITED — collectively control 74.9% of total export value, indicating a highly concentrated market. Individual shares are: UNICHEM LABORATORIES LIMITED (34.2%), FREDUN PHARMACEUTICALS LTD (19.4%), IPCA LABORATORIES LIMITED (10.8%), AUROBINDO PHARMA LTD (5.7%), MEDREICH LIMITED (4.8%).
Top Bisoprolol Exporters from India
Ranked by export value · 245 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | UNICHEM LABORATORIES LIMITED BISOPROLOL 5MG FILM-COATED TABLETSBISOPROLOL FUMARATE TABLETS USP 5MG [100BISOPROLOL FUMARATE TABLETS USP 10MG [10 | $28.9M | 12 | 34.2% |
| 2 | FREDUN PHARMACEUTICALS LTD BISOPROLOL BP 5MG + HYDROCHLORTHIAZIDE 12.5MG TABLBISOPROLOL BP 10 MG TABLETPHARMACEUTICALS PRODUCTS:BISOPROLOL USP5 MG TABLETSNOS | $16.4M | 2 | 19.4% |
| 3 | IPCA LABORATORIES LIMITED BISOPROLOL FUMARATE 10MG TABLETSBISOPROLOL 5MG FILM-COATED TABLETSBISOPROLOL 2.5MG TABLETS FILM COATED TABLETS 28 | $9.1M | 15 | 10.8% |
| 4 | AUROBINDO PHARMA LTD BISOPROLOL 5MG FILM-COATED TABLETSBISOPROLOL FUMARATE TABLETS USP 5MG [100BISOPROLOL FUMARATE TABLETS USP 10MG [10 | $4.8M | 15 | 5.7% |
| 5 | MEDREICH LIMITED BISOPROLOL 5MG FILM-COATED TABLETSBISOPROLOL 2.5MG TABLETS FILM COATED TABLETS 28BISOPROLOL 2.5MG FILM-COATED TABLETS | $4.0M | 10 | 4.8% |
| 6 | TORRENT PHARMACEUTICALS LTD BISOPROLOL FUMARATE 10MG TABLETSOTHER - BISOPROLOL FUMARATE USP 5MG TABLETSOTHER-BISOPROLOL FUMARATE USP 10MG TABLETS | $3.4M | 6 | 4.1% |
| 7 | MYLAN LABORATORIES LIMITED BISOPROLOL FUMARATE TABLETS USP 5MG [100BISOPROLOL FUMARATE TABLETS USP 10MG [10 | $2.2M | 5 | 2.6% |
| 8 | AUROBINDO PHARMA LIMITED BISOPROLOL 5MG FILM-COATED TABLETSBISOPROLOL FUMARATE TABLETS USP 5MG [100BISOPROLOL FUMARATE TABLETS USP 10MG [10 | $2.1M | 11 | 2.5% |
| 9 | HARMAN FINOCHEM LIMITED BISOPROLOL 5MG FILM-COATED TABLETSBISOPROLOL FUMARATE TABLETS USP 5MG [100BISOPROLOL FUMARATE TABLETS USP 10MG [10 | $1.1M | 2 | 1.4% |
| 10 | SAVA HEALTHCARE LIMITED AG - BISOPROLOL 5 MG BISOPROLOL FUMARATEJAMP-BISOPROLOL 5 MG BISOPROLOL FUMARATEJAMP-BISOPROLOL 5 MG BISOPROLOL FUMARATE TABLETS USP 5 MG | $1.1M | 2 | 1.3% |
| 11 | RUBICON RESEARCH PRIVATE LIMITED BISOPROLOL FUMARATE TABLETS USP 5MG [100BISOPROLOL FUMARATE TABLETS USP 10MG [10 | $1.1M | 1 | 1.3% |
| 12 | PINNACLE LIFE SCIENCE PRIVATE LIMITED BISOPROLOL FUMERATE COATED TABLETS 2.5MG 83232X3X10SKGSBISOPROLOL FUMERATE COATED TAB 5 MG (EACBISOPROLOL FUMERATE COATED TABLETS 2.5MG | $1.1M | 1 | 1.3% |
| 13 | TORRENT PHARMACEUTICALS LIMITED BISOPROLOL FUMARATE 10MG TABLETSOTHER - BISOPROLOL FUMARATE USP 5MG TABLETSOTHER-BISOPROLOL FUMARATE USP 10MG TABLETS | $945.6K | 5 | 1.1% |
| 14 | LUPIN LIMITED BILOCOR CO 10.0/6.25MG BISOPROLOL FUMABILOCOR CO (BISOPROLOL FUMARBISOPROLOL CO3X10T-UNICORN | $926.5K | 1 | 1.1% |
| 15 | LYRUS LIFE SCIENCES PRIVATE LIMITED | $897.2K | 1 | 1.1% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Bisoprolol exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Aurobindo Pharma Limited | Warning Letter, June 2019 | Unknown | Unknown | Unknown | Received FDA warning letter for cGMP deviations at Pydibhimavaram facility. |
| Unichem Laboratories Limited | Approved | Unknown | Yes | 70+ | Holds over 70 US ANDA filings and multiple European submissions. |
| Torrent Pharmaceuticals Limited | Approved | Unknown | Unknown | Unknown | Operates in over 40 countries with 2,000+ product registrations. |
| Lupin Limited | Approved | Unknown | Unknown | Unknown | Major Indian pharmaceutical company with global operations. |
TransData Nexus reviewed the regulatory standing of 4 leading Bisoprolol exporters from India. 3 hold US FDA facility approvals, 0 maintain WHO-GMP certification, and 1 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Bisoprolol sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% to the nation's bulk drug production. This prominence is bolstered by the Hyderabad Pharma City project, recognized as a National Investment Manufacturing Zone in December 2019. The city hosts numerous pharmaceutical companies specializing in active pharmaceutical ingredients (APIs) and bulk drugs, making it a pivotal hub for the initial stages of drug manufacturing.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Vadodara, in particular, is home to several pharmaceutical companies that specialize in drug formulations and ethical marketing across multiple therapeutic segments. This region's emphasis on formulations complements the bulk drug production capabilities of other clusters, ensuring a seamless transition from API manufacturing to finished dosage forms.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical products. Mumbai, being a major port city, facilitates the export of pharmaceuticals to various international markets. The region's well-established infrastructure and proximity to international shipping routes make it an ideal location for companies aiming to distribute their products globally.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, primarily due to favorable tax incentives offered by the government. These incentives have attracted numerous pharmaceutical companies to set up manufacturing units in the area, contributing to its rapid growth as a pharmaceutical hub.
5Sourcing Recommendations
- Diversify Supplier Base: Given that the top five exporters account for 74.9% of Bisoprolol shipments, it's advisable to diversify the supplier base to mitigate risks associated with over-reliance on a few sources.
- Leverage Regional Specializations: Utilize Hyderabad's expertise in bulk drug production for sourcing APIs and Ahmedabad-Vadodara's capabilities in formulations to ensure a streamlined supply chain from raw materials to finished products.
- Optimize Export Logistics: Capitalize on the Mumbai-Thane-Raigad region's infrastructure to facilitate efficient export operations, reducing lead times and transportation costs.
- Evaluate Cost Benefits: Consider the Baddi-Nalagarh region for manufacturing to take advantage of tax incentives, potentially lowering production costs and enhancing competitiveness in international markets.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Bisoprolol exporters from India
Ipca Laboratories Limited — Ipca Laboratories to acquire 33.38% stake in Unichem Laboratories for ₹1,034 crore
On April 24, 2023, Ipca Laboratories announced a definitive agreement to acquire 33.38% of Unichem Laboratories' equity share capital at ₹440 per share, totaling ₹1,034.06 crore. This acquisition is subject to approval from the Competition Commission of India (CCI).
Impact: This acquisition is expected to enhance Ipca's product portfolio and manufacturing capabilities, potentially increasing Bisoprolol exports.
Ipca Laboratories Limited — CCI approves Ipca's acquisition of 59.38% stake in Unichem Laboratories
On July 27, 2023, the Competition Commission of India approved Ipca Laboratories' proposed acquisition of up to 59.38% stake in Unichem Laboratories, subject to certain voluntary modifications.
Impact: Regulatory approval facilitates the consolidation of Ipca and Unichem's operations, likely leading to increased Bisoprolol production and export capacity.
Ipca Laboratories Limited — Ipca acquires additional 19.29% stake in Unichem Laboratories for ₹598 crore
On September 21, 2023, Ipca Laboratories acquired an additional 19.29% stake in Unichem Laboratories by purchasing 1,35,79,571 equity shares at ₹440 per share, totaling ₹597.50 crore. This transaction increased Ipca's total holding to 52.67%, making Unichem a subsidiary of Ipca.
Impact: With Unichem as a subsidiary, Ipca is positioned to leverage Unichem's manufacturing facilities, potentially boosting Bisoprolol export volumes.
Common Questions — Bisoprolol Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which bisoprolol supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, UNICHEM LABORATORIES LIMITED leads with 422 recorded shipments worth $28.9M. FREDUN PHARMACEUTICALS LTD (11 shipments) and IPCA LABORATORIES LIMITED (513 shipments) are also established high-volume exporters.
Q How many bisoprolol manufacturers are there in India?
India has 245 active bisoprolol exporters with a combined export market of $84.5M across 4,276 shipments to 121 countries. The top 5 suppliers hold 74.9% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for bisoprolol from India?
Average FOB unit price: $305.52 per unit, ranging from $0.00 to $24461.31. Average shipment value: $19.8K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 245 verified Indian exporters of Bisoprolol ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 4,276 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 121 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,276 Verified Shipments
245 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists